Int Arch Allergy Immunol:早年环境因素、IFN-γ甲基化模式和儿童过敏性鼻炎相互关系研究

2019-01-22 AlexYang MedSci原创

虽然早期生活的风险因素能够影响过敏的风险,而该现象潜在的生物学机制仍旧不清楚。最近,有研究人员调查了是否儿童时期DNA甲基化能够奠定早期生活风险因素与过敏性鼻炎的相关性。研究总共包括了234名患者,年龄6岁。其中114名为AR患者(AR组),120名为健康对照(NAR组)。研究发现,在调整了一些可能的共混杂因素后,那些母亲患有过敏的儿童的AR的可能性要比那些母亲不患有过敏的儿童更高(OR = 5.

虽然早期生活的风险因素能够影响过敏的风险,而该现象潜在的生物学机制仍旧不清楚。最近,有研究人员调查了是否儿童时期DNA甲基化能够奠定早期生活风险因素与过敏性鼻炎的相关性。

研究总共包括了234名患者,年龄6岁。其中114名为AR患者(AR组),120名为健康对照(NAR组)。研究发现,在调整了一些可能的共混杂因素后,那些母亲患有过敏的儿童的AR的可能性要比那些母亲不患有过敏的儿童更高(OR = 5.19; 95% CI 1.18-29.41);出生在秋天或者冬天的儿童要比出生在夏天或者春天更高(OR = 2.69; 95% CI 1.34-5.40);居住在具有室内地毯或者墙纸的儿童要比那些没有居住在具有室内地毯或者墙纸的儿童更高(OR = 4.14; 95% CI 2.05-8.30)。与NAR组比较,AR组具有更高的平均IFN-γ启动子区域甲基化水平,更低的IFN-γ+CD4+细胞数目与秋冬出生日期相关。另外,出生日期的季节对AR具有间接的影响,并且受平均IFN-γ启动子区域甲基化水平影响。

最后,研究人员指出,他们的研究表明了早期生活环境能够影响AR,具体表现在IFN-γ启动子区域甲基化可以作为出生季节对AR影响的一个调节因子。

原始出处:

Li Y, Rui X, Ma B et al. Early-Life Environmental Factors, IFN-γ Methylation Patterns, and Childhood Allergic Rhinitis. Int Arch Allergy Immunol. 4 Jan 2019.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2047068, encodeId=c10f204e068ee, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Aug 27 11:12:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069434, encodeId=91f72069434cf, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Wed Mar 27 04:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684030, encodeId=abcb16840303b, content=<a href='/topic/show?id=36d3e251666' target=_blank style='color:#2F92EE;'>#相互关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72516, encryptionId=36d3e251666, topicName=相互关系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34fc28021308, createdName=fengting12, createdTime=Sat May 11 11:12:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754035, encodeId=f5e21e5403517, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Sep 05 06:12:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329200, encodeId=675c1329200a5, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519041, encodeId=fa991519041a3, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540427, encodeId=58ce154042ebb, content=<a href='/topic/show?id=bb866843190' target=_blank style='color:#2F92EE;'>#环境因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68431, encryptionId=bb866843190, topicName=环境因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cd13243820, createdName=zengjiayao, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358934, encodeId=545e358934f5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Tue Jan 22 14:52:29 CST 2019, time=2019-01-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2047068, encodeId=c10f204e068ee, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Aug 27 11:12:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069434, encodeId=91f72069434cf, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Wed Mar 27 04:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684030, encodeId=abcb16840303b, content=<a href='/topic/show?id=36d3e251666' target=_blank style='color:#2F92EE;'>#相互关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72516, encryptionId=36d3e251666, topicName=相互关系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34fc28021308, createdName=fengting12, createdTime=Sat May 11 11:12:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754035, encodeId=f5e21e5403517, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Sep 05 06:12:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329200, encodeId=675c1329200a5, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519041, encodeId=fa991519041a3, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540427, encodeId=58ce154042ebb, content=<a href='/topic/show?id=bb866843190' target=_blank style='color:#2F92EE;'>#环境因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68431, encryptionId=bb866843190, topicName=环境因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cd13243820, createdName=zengjiayao, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358934, encodeId=545e358934f5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Tue Jan 22 14:52:29 CST 2019, time=2019-01-22, status=1, ipAttribution=)]
    2019-03-27 zutt
  3. [GetPortalCommentsPageByObjectIdResponse(id=2047068, encodeId=c10f204e068ee, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Aug 27 11:12:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069434, encodeId=91f72069434cf, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Wed Mar 27 04:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684030, encodeId=abcb16840303b, content=<a href='/topic/show?id=36d3e251666' target=_blank style='color:#2F92EE;'>#相互关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72516, encryptionId=36d3e251666, topicName=相互关系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34fc28021308, createdName=fengting12, createdTime=Sat May 11 11:12:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754035, encodeId=f5e21e5403517, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Sep 05 06:12:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329200, encodeId=675c1329200a5, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519041, encodeId=fa991519041a3, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540427, encodeId=58ce154042ebb, content=<a href='/topic/show?id=bb866843190' target=_blank style='color:#2F92EE;'>#环境因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68431, encryptionId=bb866843190, topicName=环境因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cd13243820, createdName=zengjiayao, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358934, encodeId=545e358934f5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Tue Jan 22 14:52:29 CST 2019, time=2019-01-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2047068, encodeId=c10f204e068ee, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Aug 27 11:12:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069434, encodeId=91f72069434cf, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Wed Mar 27 04:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684030, encodeId=abcb16840303b, content=<a href='/topic/show?id=36d3e251666' target=_blank style='color:#2F92EE;'>#相互关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72516, encryptionId=36d3e251666, topicName=相互关系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34fc28021308, createdName=fengting12, createdTime=Sat May 11 11:12:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754035, encodeId=f5e21e5403517, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Sep 05 06:12:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329200, encodeId=675c1329200a5, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519041, encodeId=fa991519041a3, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540427, encodeId=58ce154042ebb, content=<a href='/topic/show?id=bb866843190' target=_blank style='color:#2F92EE;'>#环境因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68431, encryptionId=bb866843190, topicName=环境因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cd13243820, createdName=zengjiayao, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358934, encodeId=545e358934f5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Tue Jan 22 14:52:29 CST 2019, time=2019-01-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2047068, encodeId=c10f204e068ee, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Aug 27 11:12:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069434, encodeId=91f72069434cf, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Wed Mar 27 04:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684030, encodeId=abcb16840303b, content=<a href='/topic/show?id=36d3e251666' target=_blank style='color:#2F92EE;'>#相互关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72516, encryptionId=36d3e251666, topicName=相互关系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34fc28021308, createdName=fengting12, createdTime=Sat May 11 11:12:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754035, encodeId=f5e21e5403517, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Sep 05 06:12:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329200, encodeId=675c1329200a5, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519041, encodeId=fa991519041a3, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540427, encodeId=58ce154042ebb, content=<a href='/topic/show?id=bb866843190' target=_blank style='color:#2F92EE;'>#环境因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68431, encryptionId=bb866843190, topicName=环境因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cd13243820, createdName=zengjiayao, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358934, encodeId=545e358934f5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Tue Jan 22 14:52:29 CST 2019, time=2019-01-22, status=1, ipAttribution=)]
    2019-01-24 膀胱癌
  6. [GetPortalCommentsPageByObjectIdResponse(id=2047068, encodeId=c10f204e068ee, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Aug 27 11:12:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069434, encodeId=91f72069434cf, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Wed Mar 27 04:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684030, encodeId=abcb16840303b, content=<a href='/topic/show?id=36d3e251666' target=_blank style='color:#2F92EE;'>#相互关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72516, encryptionId=36d3e251666, topicName=相互关系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34fc28021308, createdName=fengting12, createdTime=Sat May 11 11:12:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754035, encodeId=f5e21e5403517, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Sep 05 06:12:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329200, encodeId=675c1329200a5, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519041, encodeId=fa991519041a3, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540427, encodeId=58ce154042ebb, content=<a href='/topic/show?id=bb866843190' target=_blank style='color:#2F92EE;'>#环境因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68431, encryptionId=bb866843190, topicName=环境因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cd13243820, createdName=zengjiayao, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358934, encodeId=545e358934f5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Tue Jan 22 14:52:29 CST 2019, time=2019-01-22, status=1, ipAttribution=)]
    2019-01-24 heli0118
  7. [GetPortalCommentsPageByObjectIdResponse(id=2047068, encodeId=c10f204e068ee, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Aug 27 11:12:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069434, encodeId=91f72069434cf, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Wed Mar 27 04:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684030, encodeId=abcb16840303b, content=<a href='/topic/show?id=36d3e251666' target=_blank style='color:#2F92EE;'>#相互关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72516, encryptionId=36d3e251666, topicName=相互关系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34fc28021308, createdName=fengting12, createdTime=Sat May 11 11:12:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754035, encodeId=f5e21e5403517, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Sep 05 06:12:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329200, encodeId=675c1329200a5, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519041, encodeId=fa991519041a3, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540427, encodeId=58ce154042ebb, content=<a href='/topic/show?id=bb866843190' target=_blank style='color:#2F92EE;'>#环境因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68431, encryptionId=bb866843190, topicName=环境因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cd13243820, createdName=zengjiayao, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358934, encodeId=545e358934f5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Tue Jan 22 14:52:29 CST 2019, time=2019-01-22, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=2047068, encodeId=c10f204e068ee, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Aug 27 11:12:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069434, encodeId=91f72069434cf, content=<a href='/topic/show?id=c4ad28491a8' target=_blank style='color:#2F92EE;'>#儿童过敏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28491, encryptionId=c4ad28491a8, topicName=儿童过敏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Wed Mar 27 04:12:00 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684030, encodeId=abcb16840303b, content=<a href='/topic/show?id=36d3e251666' target=_blank style='color:#2F92EE;'>#相互关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72516, encryptionId=36d3e251666, topicName=相互关系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34fc28021308, createdName=fengting12, createdTime=Sat May 11 11:12:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754035, encodeId=f5e21e5403517, content=<a href='/topic/show?id=dd6f2849351' target=_blank style='color:#2F92EE;'>#儿童过敏性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28493, encryptionId=dd6f2849351, topicName=儿童过敏性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aff136654610, createdName=charl1234579, createdTime=Thu Sep 05 06:12:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329200, encodeId=675c1329200a5, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519041, encodeId=fa991519041a3, content=<a href='/topic/show?id=ba989452f5' target=_blank style='color:#2F92EE;'>#IFN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9452, encryptionId=ba989452f5, topicName=IFN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540427, encodeId=58ce154042ebb, content=<a href='/topic/show?id=bb866843190' target=_blank style='color:#2F92EE;'>#环境因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68431, encryptionId=bb866843190, topicName=环境因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cd13243820, createdName=zengjiayao, createdTime=Thu Jan 24 04:12:00 CST 2019, time=2019-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358934, encodeId=545e358934f5, content=感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30251637888, createdName=lietome15, createdTime=Tue Jan 22 14:52:29 CST 2019, time=2019-01-22, status=1, ipAttribution=)]
    2019-01-22 lietome15

    感谢小编为我们准备了如此丰盛的精神大餐,同时也向作者致谢!认真学习了,点赞!

    0

相关资讯

Medicine (Baltimore):针灸在过敏性鼻炎患者中的治疗效果研究

最近,有研究人员在舌下特异性过敏原免疫治疗(SASIT)的过敏性鼻炎(AR)患者中,回顾性的分析了针灸疗法作为一种附加的疗法(AAOT)对过敏性鼻炎患者的治疗效果。研究总共包括了120名符合研究标准的AR成年人患者。其中60名患者接受了AAOT和SASIT治疗,并作为治疗组,其他60名受试者只接受了SASIT治疗,并作为对照组。主要结果为AR症状,次级结果为通过鼻炎生活质量调查问卷(RQLQ)评估

Medicine (Baltimore):过敏性鼻炎与阻塞性睡眠呼吸暂停相关性元分析

过敏性鼻炎(AR)与阻塞性睡眠呼吸暂停(OSA)共存是临床实践上的一种常见现象。AR长久以来被认为是OSA的一种风险因子。然而,相关关系仍旧不完全清楚。因此,最近,有研究人员进行了元分析来评估睡眠障碍性呼吸(SDB/)OSA中AR的流行度以及它们之间的关系。元分析总共包括了44个已经报道的研究,总共有6086名参与者。对成年人来讲,SDB患者中AR的流行度为22.8%(95% CI, 15.0-3

Clin Exp Allergy:桦树花粉过敏皮下免疫治疗的效果和安全性评价

之前的桦树花粉皮下免疫治疗的临床试验一般进行1-2年的治疗周期,并且地理位置经常是单一的。最近,有研究人员在19个欧洲中心进行了为期3年的研究,他们评估了高剂量低致敏性桦树花粉过敏原皮下免疫治疗对那些确诊患有中度到重度季节过敏性鼻炎/鼻窦炎患者的治疗效果。研究包括了253名桦树花粉过敏患者,并随机分配到季节前安慰剂组(n=129)和积极治疗组(n=124)。研究发现,积极治疗vs安慰剂治疗患者的症

Eur Rev Med Pharmacol Sci:miR-487b能够通过对IL-33/ST2信号途径的抑制减轻过敏性鼻炎

最近,有研究人员调查了miR-487b/IL-33-ST2途径对过敏性鼻炎(AR)病理的潜在影响和相关的机制。研究人员在患有和不患有过敏性鼻炎的患者中检测了IL-33、磺基转移酶同系物(ST2)和miR-487b的表达水平,并利用荧光素酶报告试验评估了miR-487b与IL-33之间的互作。研究人员还利用小鼠模型来探究miR-487b/IL-33-ST2途径对过敏性鼻炎的影响。研究发现,IL-33

Int J Pediatr Otorhinolaryngol:早期家庭环境和疾病情况与过敏性鼻炎相关

尽管对过敏性鼻炎(AR)很关注,但是过敏性鼻炎相关的风险因子仍旧不清楚。最近,有研究人员分析了早期生活的家庭环境和疾病与AR之间的相关性。研究是一个案例-对照研究,包括了242名AR患者和258名健康对照。他们完成了调查问卷来调查早期生活的相关疾病情况、家族过敏历史和家庭环境因素。研究人员调查了与AR相关的40个风险因素并进行了卡方检验和逻辑回归分析。研究发现,母亲患的疾病(比如牙周炎,慢性鼻炎,

Int J Pediatr Otorhinolaryngol:季节性过敏性鼻炎中,DNA甲基化模式鉴定

最近,有研究人员鉴定了季节过敏性鼻炎中,明显的DNA甲基化模式。研究人员从ArrayExpress数据库中获得了E-GEOD-5022的甲基化概况,并根据甲基化数据对差异共甲基化网络(DCN)进行了构建。从DCN中,研究人员鉴定了多重差异化的模式(M-DMs)。研究人员还将明显的模式定位到具体的途径中,从而鉴定富集的途径。最后,研究人员指出,在DCN中,共鉴定了16个种子基因,并利用这16个种子基